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Novel Leptin-Regulated Genes Revealed by Transcriptional
Profiling of the Hypothalamic Paraventricular Nucleus
Yi-Chun Loraine Tung, Marcella Ma, Sarah Piper, Anthony Coll, Stephen O’Rahilly, and Giles S. H. Yeo
University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, United Kingdom
Leptin plays amajor role in coordinating the integrated response of the CNS to changes in nutritional state. Neurons within the paraven-
tricular nucleus (PVN) of the hypothalamus express leptin receptors and receive dense innervation from leptin receptor-expressing
neurons in the arcuate nucleus. To obtain new insights into the effects of circulating leptin on PVN function, we compared global
transcriptional profiles of laser-captured PVN from ad libitum fedmice versus 48 h fastedmice receiving either shamor leptin treatment
intraperitoneally. Five hundred twenty-seven PVN-expressed genes were altered by fasting in a manner that was at least partially
reversible by leptin. Consistent with previous reports, thyrotrophin releasing hormone mRNA levels were decreased by fasting but
restored to fed levels with leptin treatment. mRNA levels of oxytocin, vasopressin, and somatostatin were also reduced by fasting and
restoredby leptin. Given the knowneffects of leptin on synaptic remodeling, it is notable that, among the top 15 genes thatwere positively
regulated by leptin, five have been implicated in synaptic function and/or plasticity (basigin, apolipoprotein E, Gap43, GABAA receptor-
associated protein, and synuclein-). Pathway analysis identified oxidative phosphorylation, in particular, genes encoding complex 1
proteins that play a role in ubiquinonebiosynthesis, to be the predominant gene set thatwas significantly regulated in a leptin-dependent
manner. Thus, in addition to its effects on the expressionof a broad range of neuropeptides, leptinmay also exertmore general influences
on synaptic function in, and the bioenergetic state of, the PVN.
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Introduction
Leptin is an adipocyte-derived hormone that plays a critical role
in energy homeostasis. Circulating concentrations of leptin mir-
ror fat cell stores, being increased in overfeeding but decreased
with prolonged fasting. Robust data indicate that leptin acts pri-
marily through the CNS to regulate food intake and energy ex-
penditure (for review, see Coll et al., 2007; Oswal and Yeo, 2007).
Within the CNS, the hypothalamus in particular is recognized to
receive and integrate neural, metabolic, and humoral signals
from the periphery. The hypothalamus is a heterogeneous region
encompassing a number of anatomically discrete nuclei. For ex-
ample, the arcuate nucleus (Arc) contains two distinct neuronal
populations expressing either neuropeptide Y and agouti-related
peptide (AgRP) or proopiomelanocortin and cocaine and
amphetamine-related transcript. Both express the long form of
the leptin receptor (ObRb) and are considered to be key first-
order neurons through which leptin exerts its effects.
Another important hypothalamic region involved in energy
homeostasis is the paraventricular nucleus (PVN). In addition to
containing neurons that themselves express ObRb, the PVN re-
ceives dense innervation from leptin receptor-expressing neu-
rons in the Arc, thereby allowing leptin to both directly and in-
directly affect PVNneuronal activity. Furthermore, not only does
lesioning of the PVN in rodents bring about marked hyperpha-
gia, but also loss of a single allele of Sim1, a gene encoding a
transcription factor critical for the normal development of the
PVN (Michaud et al., 1998), causes obesity in both humans and
mice (Holder et al., 2000;Michaud et al., 2001). Additionally, the
reactivation ofmelanocortin 4-receptor (Mc4r) solely in the PVN
completely corrects the hyperphagia found in Mc4r null mice
(Balthasar et al., 2005), a well characterized obese mouse model
of obesity resulting from disrupted central melanocortinergic
signaling (Huszar et al., 1997).
The precise mechanisms by which changes in neuronal activ-
ity within these important hypothalamic nuclei are translated
into changes in food intake and energy expenditure remains to be
clearly established. In particular, themolecules and pathways that
mediate the action of leptin in the PVN, either directly or indi-
rectly via the melanocortin pathway, remain to be fully
elucidated.
In this study, we have used laser-captured microdissection
(LCM) coupled with transcriptional profiling to gain insights
into the leptin-dependent mechanisms at work within the PVN.
Reasoning that genes with a physiological role in energy ho-
meostasis are likely to be nutritionally regulated, we have identi-
fied genes in the PVNwhose expression is (1) altered in response
to a substantial fast (a state of relative leptin deficiency) and (2)
restored toward ad libitum fed values with leptin treatment alone.
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To allow discrimination between changes in gene expression that
may have occurred as a result of the stress of fasting rather than
via a leptin-dependent mechanism, we also analyzed in the same
animals the transcriptome of the cerebellum, a brain region that
does not express ObRb and has no known role in the control of
energy balance.
Materials andMethods
In vivomurine studies. All animal studies were performed in male SV129
mice purchased from Charles River. Before all procedures, animals were
allowed to acclimatize for at least 1 week. Animals were kept at 22°C on a
12 h light/dark cycle (lights on from7:00 A.M. to 7:00 P.M.). The animals
were fed on standard laboratory chow (Special Diet Services) and had
access to water ad libitum throughout. All mice were matched for body
weight at the start of the experiment. All experimental procedureswere in
accordance with regulations and guidelines of the United Kingdom
Home Office.
We used the protocol as described by Ahima et al. (1996) for the
maintenance of serum leptin levels during a fast. Ten-week-old mice
were divided into three weight-matched groups (n 4 in each group for
microarray; n  8 for TaqMan confirmation). Group one (fed) had ad
libitum access to chow, and group two (fasted) had all food removed at
the onset of light cycle and remained fasted for 48 h. Both groups received
twice daily intraperitoneal injection of saline. Group three (fasted plus
leptin) had all food removed at the onset of light cycle and remained
fasted for 48 h but received twice daily intraperitoneal injection of re-
combinant murine leptin (Amgen) at a dose of 1g/g total body weight.
At the end of the experiment, the body weights of ad libitum fed, fasted,
and fasted plus leptin mice were 28.1 0.5, 22.7 0.3, and 22.9 0.3 g,
respectively. All animals were killed by cervical dislocation 12 h after the
last injection. The brains were removed and immediately frozen on pow-
dered dry ice and stored at80°C until additional processing.
Laser-captured microdissection and total RNA isolation. Coronal sec-
tions of 14 m thickness were prepared on a cryostat and mounted on
RNase-free membrane-coated glass slides (P.A.L.M. Membrane Slides;
P.A.L.M. MicrolaserTechnologies). Slides were kept in a slide box em-
bedded in dry ice until sectioning was completed. Within 24 h after
sectioning, the frozen sections were thawed and fixed for 30 s in 95%
ethanol and then rehydrated (75 and 50% ethanol, 30 s each). After
fixation, the slides were stained with 1% cresyl violet for 1 min. The
sections were then dehydrated in a graded ethanol series (50%, 75%,
95%, and two times for 100%, 30 s each), followed by Histoclear for 5
min. All the solutions were prepared with RNase-free water (Ambion).
Lasermicrodissectionwas performedusing a P.A.L.M.MicrolaserSystem
(P.A.L.M.Microlaser Technologies). The hypothalamic PVNwasmicro-
dissected covering the region from0.7 to1.22 mm caudal to bregma
(37 sections) as defined by Paxinos and Franklin (2001). All evenly
spaced sections were pooled to eliminate any potential rostrocaudal gene
expression bias. After each microdissection, the captured cells were kept
in RNAlater (Ambion) before RNA isolation. Total RNA was isolated
according to the protocol of the manufacturer using the RNAqueous-
Micro kit (Ambion). Quality and quantity of the total RNA samples were
determined by electrophoresis using the Agilent BioAnalyzer. Before
RNA amplification, the more sensitive Agilent BioAnalyzer PicoChip
was used (according to the instructions of the manufacturer). To deter-
mine the RNA concentration, a dilution series of a control with known
concentration was run alongside the nuclei samples.
RNA amplification and microarray hybridization. To minimize bias,
isolated total RNA (n  4 per group) was subjected to two rounds of
T7-based liner amplification. Briefly, RNA was primed with a T7 pro-
moter oligo-dT primer and reverse transcribed to generate first-strand
cDNA, which was used as the template to synthesize second-strand
cDNA byDNA polymerase (Two-cycle cDNA Synthesis kit; Affymetrix).
The T7 RNA polymerase promoter contained by double-stranded (ds)
cDNA molecules was used, by T7 polymerase, to transcribe antisense
amplified RNA (aRNA) (MEGAscript T7 kit; Ambion). The aRNA was
then randomly primed to make single-stranded cDNA with a 3 poly(A)
tail to serve as the template for second-strand cDNA synthesis primed, as
in the first round, with a T7 promoter oligo-dT primer tomake ds cDNA
containing a T7 promoter site. A second transcription step using T7
polymerase produced the second round of aRNA with biotin-labeled
ribonucleotide (GeneChip IVT labeling kit; Affymetrix). The biotin-
labeled cRNA were then fragmented, and the average fragment length
was determined using an Agilent BioAnalyzer 2100 and hybridized to
Affymetrix Murine 430 2.0 oligonucleotide microarrays. The hybridized
probe array is stained with streptavidin phycoerythrin conjugate and
scanned on an Affymetrix GeneChip 7G scanner.
Microarray analysis. Raw image data were converted to CEL and pivot
files using Affymetrix GeneChip Operating Software (GCOS). All down-
stream analysis ofmicroarray datawere performed usingGeneSpringGX
7.3 (Agilent). The pivot files were used in the GCOS analysis and theCEL
files were used for both the robust multiarray average (RMA) (Irizarry et
al., 2003) and GCh robust multiarray average (GCRMA) (Wu et al.,
2003) analyses. After importing the data, each chipwas normalized to the
50th centile of the measurements taken from that chip, and all gene
expression data are reported as fold change from the “fed” state. Genes
were considered to be “leptin regulated” if they were significantly up-
regulated or downregulated by at least 1.5-fold in the fasted state and (1)
returned to within 1.3-fold of the fed state with leptin treatment or (2)
changed by more than threefold from the fasted state with leptin treat-
ment. Statistical analysis was performed using a one-sample Student’s t
test, looking for statistically differentially expressed genes within each
condition. The test was applied to the mean of each normalized value
against the baseline value of 1, atwhich genes donot showany differential
expression with respect to the control. We considered p  0.05 to be
significant. Only genes that met the above criteria using GCOS, RMA,
and GCRMA were taken forward for additional study.
Gene Tree “heat maps” were implemented by GeneSpring GX 7.3
using Pearson’s correlation for similaritymeasure and an average linkage
clustering algorithm. Pathway analysis was performed using Ingenuity
Pathway Analysis (Ingenuity Systems).
Quantitative PCR analysis. Quantitative PCR (Q-PCR) analysis was
performed using TaqManGene Expression assays on purified RNA sam-
ples. Total RNA were amplified as described for microarray. Two nano-
grams of isolated total RNA from each nucleus was subjected to two
rounds of T7-based linear amplification. Amplified RNA, 100 ng, from
laser-captured microdissected samples were used in a random-primed
first-strand cDNA synthesis reaction, using superscript II reverse tran-
scriptase (Invitrogen). The resulting first-strand cDNA reaction was di-
luted 2.5-fold, and 2 l was used in each 12 l of TaqMan reaction.
Quantitative PCR reactions were performed in triplicate on an ABI
7900HT (Applied Biosystems) and usingABI PCRmastermix, according
to the protocols of themanufacturer. Expression results were normalized
to 18S, -actin, and B2M. Quantitative PCR statistical analysis was per-
formed usingMicrosoft Excel. p values were calculated using a two-tailed
distribution unpaired Student’s t test. Data are expressed as mean 
SEM.
Results
Validation of laser capture and of
fasting/fed/leptin paradigms
To ensure the specificity of the PVN dissection (Fig. 1a) within
laser-captured material, we examined expression of a number of
genes that are only found in neighboring hypothalamic nuclei.
As expected, we were unable to detect expression of ARC-
specific Agrp, ventromedial nuclei-specific Sf-1, and lateral
hypothalamus-specific melanin concentrating hormone (Mch)
within any PVN sample (data not shown). In addition, we exam-
ined expression of the gene encoding thyrotrophin releasing hor-
mone (TRH), a well characterized hypothalamic peptide known
to be highly expressed within the parvocellular region of the PVN
(Flament-Durand, 1980) and known to be nutritionally regu-
lated in a leptin-dependent manner (Haˆkansson et al., 1998; Isse
et al., 1999; Harris et al., 2001). Using TaqMan Q-PCR TRH
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mRNA was decreased by fasting in LCM PVN samples, with this
effect being significantly blunted by leptin replacement (Fig. 1b).
Analysis of microarrays using three different algorithms
We proceeded to hybridize the PVN RNA samples to murine
whole genome oligonucleotide arrays (Affymetrix). To discrimi-
nate between PVN-specific changes and a
more generalized brain-wide response to
stress of a prolonged fast, gene expression
profiles were also obtained from samples
of cerebellum removed from the same
mice. All genes whose expression within
the cerebellumwas alteredwith fasting in a
leptin-regulated manner were excluded
from additional analysis (n 280).
To maintain maximum stringency and
reduce the number of false positives, we
analyzed the data using three different al-
gorithms: (1) GCOS, (2) RMA (Irizarry et
al., 2003), and (3) GCRMA (Wu et al.,
2003). Only genes whose expression pat-
terns in each of the three analyses were
identical were taken forward for additional
study.
The three analyses gave very different
results from the same experimental data.
GCOS indicated that the expression of 932
genes were downregulated in fasting but
returned toward fed levels with leptin (Fig.
2a). The number of genes with this expres-
sion profile was 2214 with RMA and 1966
with GCRMA, with only 438 genes having
identical expression patterns across all
three analytical platforms (Fig. 2a) (sup-
plemental Table 1, available at www.
jneurosci.org as supplemental material).
Similar to genes upregulated by fasting but
normalized with leptin, GCOS, RMA, and
GCRMA analyses determined that 382,
343, and 457 genes, respectively, followed
this expression profile (Fig. 2b). Only 89 of
these genes satisfied the criterion of con-
cordance across all three analyses (supple-
mental Table 2, available at www.
jneurosci.org as supplemental material).
Figure 3a shows a heat map of the 527
leptin-regulated genes, and b and c repre-
sent the same data by plotting the average
normalized signal intensities of the leptin-
regulated genes from the fasted (Fig. 3b)
and fasted plus leptin (Fig. 3c) groups on
the y-axes, respectively, against the fed
group on the x-axis.
Genes downregulated by fasting but
normalized by leptin
The major effect of leptin was to restore
toward normal genes whose expression
levels were downregulated by fasting. Fig-
ure 4a lists the 25 transcripts that showed
the largest downregulation in expression
in the fasted state that were normalized by
leptin. Consistent with our Q-PCR data
(Fig. 1b), the fifth gene on this list is Trh, whose expression is
downregulated 10-fold in fasting and is rescued to 50% of fed
levels. Among the top 25 genes positively regulated by leptin are
two well known neuropeptides of the PVN, oxytocin and vaso-
pressin. In addition, somatostatin gene expression (supplemental
Table 1, available at www.jneurosci.org as supplemental mate-
Figure 1. a, Laser-capturedmicrodissection of the hypothalamic PVN. Brain atlas inserts are taken from Paxinos and Franklin
(2001). b, Trh is nutritionally and leptin regulated in the PVN. Bar graphs show the change in expression of Trh in the PVN of the
hypothalamus in the fed, fasted, and leptin-treated-while-fasted state. Response is normalized to 18S and is expressed in terms
of fold induction of the fasted and leptin-treated expression over the fed expression. p values were calculated using a two-tailed
distribution unpaired Student’s t test. Data are represented as themean SE of at least six independentmice per group. **p
0.01.
Figure 2. Venn diagram comparing the three different analyses: GCOS, RMA, and GCRMA. a, The 438 genes downregulated in
fasting rescued by leptin. b, The 89 genes upregulated in fasting rescued by leptin. Numbers in parentheses indicate the number
of genes regulated by leptin (see Materials and Methods) as determined by either the GCOS, RMA, or GCRMA algorithms.
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rial) was significantly regulated in a similar manner. These data
were validated in an independent biological replicate of this ex-
periment using Q-PCR (Fig. 5a).
In addition to its role in regulation of neuropeptide expres-
sion, leptin has been shown recently to have important structural
effects on synaptic density and remodeling within the arcuate
nucleus (Pinto et al., 2004). Notably, among the top 25 genes
positively regulated by leptin in the PVN (Fig. 4a) are several that
have been implicated in synaptic function. These include the
most highly leptin-regulated gene thatwe identified, namely basi-
gin (Bsg), as well as apolipoprotein E (ApoE), Gap43, synuclein-,
and GABAA receptor-associated protein (Gabarap). The effects of
leptin on the expression of Bsg, ApoE, Gap43, and Gabarap were
also measured by Q-PCR in an independent biological replicated
experiment. The direction of the effect was confirmed for all four
genes, but, in the case of ApoE, this did not reach statistical sig-
nificance (Fig. 5b).
The seventh gene on this list is neuronatin. It has been impli-
cated to play a role in neurodevelopment and is also highly ex-
pressed in pancreatic -cells in which it may play a role in insulin
secretion (Joe et al., 2008) as well as in adipocytes (Suh et al.,
2005). The expression profile of neuronatin was also validated by
Q-PCR (Fig. 5b).
Genes upregulated by fasting but normalized by leptin
Figure 4b lists the 25 transcripts that showed the greatest upregu-
lation in expression in the fasted state that were normalized by
leptin. The transcript at the top of the list isNeto1 (neuropilin and
tolloid-like 1), which encodes a brain-specific transmembrane
protein with structural similarity to neuropilin (Sto¨hr et al.,
2002). Sorcs1 (sortilin-related VPS10 domain containing recep-
tor 1), the second gene on the list, has been implicated recently as
a susceptibility gene in obesity-induced type 2 diabetes mellitus
(T2D) (Clee et al., 2006; Goodarzi et al., 2007). Cntnap2, the
fourth gene on the list, encodes a member of the neurexin family
that functions in the vertebrate nervous system as cell adhesion
molecules and receptors (Poliak et al., 1999).
Pathway analysis
We further analyzed the data using a pathway analysis package
(Ingenuity Pathway Analysis) that detects groups of functionally
related annotated genes.
The mitochondrial oxidative phosphorylation (OXPHOS)
pathway was highly significantly over-represented ( p  5.01E-
16) in the list of genes whose expression was downregulated in
fasting and reversed by leptin (Fig. 6). Twenty-six of 158 OX-
PHOS genes were present in the 438 genes. In particular, 12 of
these genes were from the complex I ubiquinone biosynthesis
pathway. To confirm this observation, we performed Q-PCR on
eight OXPHOS genes present in a biological replicate of the ex-
periment as described above. Three were from complex I
(Ndufa8, Ndufb9, and Ndufs7), one from each of complexes II,
III, and IV (Sdhd,Uqcrc2, andCox5a, respectively), and two from
complex V (Atp6v1f andAtp5 g). The OXPHOS genes from com-
plexes I–IV showed fasting-induced downregulation that was re-
versed by leptin (Fig. 7); Atp6v1f and Atp5g from complex V
showed no change in expression (data not shown). In keeping
with the microarray results, the fasting-induced expression
downregulation of these six genes was modest (between 1.5-fold
and 2-fold downregulated), with only the downregulation of
Ndufa8, Sdhd, and Cox5a reaching statistical significance ( p 
0.05). However, the trend to downregulation and the reversal by
leptin was present in all six genes, supporting the pathway anal-
ysis and providing additional evidence that multiple genes from
theOXPHOSpathway are downregulated in the PVN in response
to fasting and are regulated by leptin.
Genes involved in protein synthesis are also significantly ( p
8.83E-6) over-represented in our list of genes positively regulated
by leptin, with 41 of the 438 genes (9.3%) involved.
Figure 3. a, Heat map of 527 leptin-regulated genes. Blue color indicates downregulation,
and red/orange color indicates upregulation comparedwith the fed state. b, Scatter plot of 527
leptin-regulated genes in the fasting state. Plot of the average normalized signal intensities of
the leptin-regulated genes from the fasted group on the y-axis against the fed group on the
x-axis. Open circles represent the89genesupregulated in fasting, and filled circles represent the
438 genes downregulated in fasting. c, Scatter plot of 527 leptin-regulated geneswhen treated
with leptin. Plot of the average normalized signal intensities of the leptin-regulated genes from
the fasted plus leptin group on the y-axis against the fed group on the x-axis. Open circles
represent the 89 genes upregulated in fasting, and filled circles represent the 438 genes down-
regulated in fasting.
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Discussion
To gain insights into molecules and pathways mediating down-
stream signaling actions of leptin in the PVN, a key hypothalamic
region involved in energy balance, we compared the expression
profiles of laser-captured PVN from ad libitum fed mice, 48 h
fasted mice, and mice given leptin during a similar fast. To ex-
clude transcripts representing nonspecific neuronal stress re-
sponses to fasting, we simultaneously profiled the cerebellum, a
site unknown to have a regulatory role in energy balance. The
specificity of the LCMcould be confirmed visually (Fig. 1a) and is
also supported by the absence of Agrp, Sf-1, andMch transcripts
from the samples. Additionally, we confirmed using Q-PCR that
the PVN samples showed the expected regulation of TRHmRNA
by fasting and feeding.
To minimize false positives, we were
stringent in handling our data. Rather
than rely solely on Affymetrix GCOS soft-
ware, we also analyzed our data using
RMA and GCRMA. After applying these
different analyses, only 20–30% of all the
genes overlapped between all three algo-
rithms. However, it was clear that the big-
gest dataset (n  438) was of genes posi-
tively regulated by leptin.
Neuropeptide gene expression positively
regulated by leptin
Oxytocin, vasopressin, and somatostatin
gene expression was reduced by fasting
and restored by leptin (Fig. 5a). This is
consistent with reports showing a fasting
reduction in hypothalamic oxytocin
mRNA levels that was reversed by refeed-
ing (Kublaoui et al., 2008) and the re-
ported role of oxytocin neurons linking
hypothalamic leptin-action to caudal
brainstem nuclei controlling meal size
(Blevins et al., 2004). Arginine vasopressin
expression in the PVN has been shown to
be increased by leptin (Yamamoto et al.,
1999). Previous reports demonstrating the
presence of leptin receptors on PVNmag-
nocellular vasopressin- and oxytocin-
containing neurons (Haˆkansson et al.,
1998) indicate that this effect could result
from direct leptin action. Additionally, so-
matostatin has been demonstrated to
modulate the efficacy of leptin signaling in
the rat hypothalamus (Stepanyan et al.,
2007).
Synaptic remodeling/plasticity genes
positively regulated by leptin
Four of the top 15 genes positively regu-
lated by leptin (Basigin, ApoE, Gap43, and
Gabarap) are involved in synaptic mainte-
nance or development. Bsg is part of a
transsynaptic complex regulating synaptic
compartmentalization and strength, and
coordinating plasma membrane and cor-
tical organization (Besse et al., 2007).
ApoE receptors act as signaling molecules
in neurons, altering phosphorylation of
numerous proteins after extracellular ligand binding and affect-
ing neurite outgrowth, synapse formation, and neuronal migra-
tion (Hoe et al., 2006). Gap43 is a neuronal-specific gene that
plays a role in actin regulation, neurite outgrowth, and anatom-
ical plasticity (Frey et al., 2000). Gabarap traffics GABAA recep-
tors to and from the cell surface, clustering these neurotransmit-
ter receptors at the postsynaptic terminals (Chen et al., 2000; Leil
et al., 2004), which is a critical requirement for efficient neuro-
transmission and neuronal communication.
It is becoming clear that, in addition to engaging classical
“neuropeptide/receptor” systems within the brain, leptin also
rapidly modifies synaptic connections between neurons. Leptin
has been demonstrated to be necessary for both normal develop-
ment of neuronal projections within the hypothalamus (Bouret
Figure4. Top25genes that are positively (a) andnegatively (b) regulatedby leptin in thePVN. Changes ingeneexpression are
expressed as fold induction of the fasted or leptin-treated expression over the respective fed expression. Negative numbers
indicate downregulation. Genes are ranked by fasting fold change. Genes were considered to be leptin regulated if they were
significantly upregulated or downregulated by at least 1.5-fold in the fasted state and returned towithin 1.3-fold of the fed state
with leptin treatment or changed by more than threefold from the fasted state with leptin treatment.
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et al., 2004) as well as in the regulation of synaptic plasticity
(Pinto et al., 2004; Horvath and Gao, 2005; Sternson et al., 2005;
Gao et al., 2007). The use-dependent potentiation of excitatory
synapses onto pyramidal cells in the hippocampus is a well stud-
ied form of synaptic plasticity (Kullmann and Lamsa, 2007). The
identification in this study of leptin-regulated genes that play a
variety of roles in synapse development or plasticity supports the
notion that similar mechanisms to those seen in the hippocam-
pus (O’Malley et al.,2007) maybe active within the
hypothalamus.
Genes expressed in the brain and periphery positively
regulated by leptin
Neuronatin and synuclein- are highly expressed in both the brain
and metabolic relevant peripheral tissues. Neuronatin was first
identified in the developing mammalian brain (Joseph et al.,
1994) but is also expressed in the pancreas in which it plays a role
in insulin secretion (Joe et al., 2008) and in adipocytes in which it
may have a role in adipogenesis (Suh et al., 2005). Synuclein- is
abundant in the neuronal cytosol and enriched at presynaptic
terminals (Clayton andGeorge, 1998).However, like neuronatin,
it has also been found to be highly expressed in white adipose
tissue, in which it is coordinately expressed with leptin and in-
creased in human obesity (Oort et al., 2008). It is intriguing that
adipose tissue and leptin-responsive neurons in the brain could
share some nutrient-sensing mechanisms.
Genes negatively regulated by leptin
Our data indicates that there are fewer genes that are negatively
regulated by leptin. However, the first (Neto1) and the fourth
(Cntnap2) genes on this list also have a role in neuronal develop-
ment. Neto1 encodes a brain-specific transmembrane protein,
whose expression pattern and structural similarity with neuropi-
lin suggested that it possibly played a role in the development
and/or maintenance of neuronal circuitry (Sto¨hr et al., 2002),
whereas Cntnap2 is a member of the neurexin family, which
functions in vertebrate nervous systems as cell adhesion mole-
cules and receptors (Poliak et al., 1999). Thus, it appears that
leptin can positively and negatively regulate genes involved in
neuronal development, providing more evidence that structural
changes to hypothalamic neurons may play a role in mediating
the actions of leptin.
Sorcs1, another gene negatively regulated by leptin, was iden-
tified inmice as a quantitative trait locus for T2D affecting fasting
insulin levels (Clee et al., 2006). A recent study translating these
results in humans identified significant associations between
SORCS1 variants and fasting insulin levels, as well as T2D risk in
female subjects, in two Mexican-American populations. Goo-
darzi et al. (2007) has hypothesized that it may play a role in the
maintenance or expansion of islet vasculature during islet growth
in compensation for insulin resistance. However, SORCS1 is also
highly expressed in neurons in which it probably plays a role in
cell trafficking, with one of itsmajor isoforms interactingwith the
C/2 subunits of the adaptor protein-2 complex (Nielsen et al.,
2008). The fact that this gene is nutritionally regulated in a leptin-
dependent manner warrants additional investigation.
Pathway analysis
To identify pathways or functional annotations that maybe over-
represented in the expression data, we performed pathway anal-
yses of genes both positively and negatively regulated by leptin.
We did not identify any coordinated pathways or functions neg-
atively regulated by leptin. However, analysis of the 438 genes
Figure 6. Ingenuity pathway analysis of 438 genes positively regulated by leptin.
Figure 5. TaqMan quantitative PCR validation of genes positively regulated by leptin. Bar
graphs show the change in expression of neuroendocrine genes (a) and genes involved in
neuronal development (b) in the PVN of the hypothalamus in the fed, fasted, and leptin-
treated-while-fasted state. Response is normalized to 18S and is expressed in terms of fold
induction of the fasted and leptin-treated expression over the fed expression. p values were
calculated using a two-tailed distribution unpaired Student’s t test. Data are represented as the
mean SE of at least six independent mice per group. *p 0.05; **p 0.01.
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positively regulated by leptin revealed multiple genes involved in
protein synthesis as well as from the mitochondrial OXPHOS
pathway.
Recent evidence supports the view that protein synthesis oc-
curs in axons, remote from the cell body, and is integral to aspects
of synaptogenesis and axonal development (Piper and Holt,
2004). Thus, the fact that 9% of the genes positively regulated by
leptin are involved in protein synthesis is congruent with the
similar regulation of synaptic remodeling genes.
Of the 158 genes Ingenuity Pathway Analysis has categorized
as being part of the OXPHOS pathway, 26 were present in the list
of 438 genes. When eight of these genes were validated using
Q-PCR, all the ones from complexes I–IV recapitulated the mi-
croarray data, whereas the two genes tested from complex V did
not.
The hypothalamus integrates both hormonal and nutritional
signals to achieve energy balance (Coll et al., 2007; Oswal and
Yeo, 2007). Thus, our finding that OXPHOS gene expression
decreases in the PVN in response to fasting suggests that a switch
fromoxidative to nonoxidativemetabolismmaybe important for
the hypothalamic homeostatic response to nutrient deprivation
and reduced leptinergic tone. A number of studies have reported
that expression of OXPHOS genes are coordinately decreased in
skeletalmuscle frompatientswithT2D (Mootha et al., 2003; Patti
et al., 2003), a condition closely linked with obesity (Kahn and
Flier, 2000). Enormous interest is currently being expressed in
the hypothalamus as a critical site for the coordinated control of
both glucose homeostasis and energy balance (Obici et al., 2001;
Obici and Rossetti, 2003; Lam et al., 2005). Our findings raise the
possibility that regulation of OXPHOS gene expression maybe a
unifying mechanism important for the control of energy balance
and nutrient handling in both the hypothalamus and periphery
and that dysregulation of this coordinated pattern of gene expres-
sion might underlie both obesity and diabetes.
Caveats
Although our usage of LCM has improved our “resolution” in
studying gene expression in the hypothalamus, the PVN is still
very heterogeneous, including both parvocellular andmagnocel-
lular neurons. Additionally, although somePVNneurons express
leptin receptors, activity-dependent
changes in other regions, particularly the
ARC, are likely contributors to the ob-
served transcriptional changes. This study
did not allow us to discriminate between
direct and indirect actions of leptin, which
would require future studies profiling in-
dividually identified neurons.
Conclusions
Leptin, a circulating hormone produced in
adipose tissue, influences the expression of
a large number of genes within the PVN,
most ofwhich it positively regulates. In ad-
dition to certain classical neuropeptides,
leptin also has striking effects on the ex-
pression of a number of genes implicated
in synaptic function and/or plasticity. Fi-
nally, leptin appears to exert a generalized
positive effect on the expression of genes
involved in mitochondrial OXPHOS. Ad-
ditional work will be required to deter-
mine which, if any, of these effects are crit-
ical for the multiple actions of leptin, including the control of
bodyweight.
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